PetVivo Holdings Inc

+0.06 (+2.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)22.65M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.15 Million
Adjusted EPS-$0.21
See more estimates
10-Day MA$2.07
50-Day MA$2.41
200-Day MA$2.48
See more pivots

PetVivo Holdings Inc Stock, NASDAQ:PETV

5251 Edina Industrial Boulevard, 5251 Edina Industrial Boulevard, Minneapolis, Minnesota 55439
United States of America
Phone: +1.952.405.6216
Number of Employees:


PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.